In8bio Shares Owned By Insiders vs. Current Valuation
| INAB Stock | USD 0.31 0.01 3.33% |
For In8bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of In8bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well In8bio Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between In8bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of In8bio Inc over time as well as its relative position and ranking within its peers.
In8bio |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Return On Assets (0.78) | Return On Equity (1.80) |
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
In8bio Inc Current Valuation vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining In8bio's current stock value. Our valuation model uses many indicators to compare In8bio value to that of its competitors to determine the firm's financial worth. In8bio Inc is rated fourth overall in shares owned by insiders category among its peers. It is rated below average in current valuation category among its peers reporting about 1,090,089 of Current Valuation per Shares Owned By Insiders. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the In8bio's earnings, one of the primary drivers of an investment's value.In8bio Current Valuation vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
In8bio |
| = | 21.55 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
In8bio |
| = | 23.49 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
In8bio Current Valuation vs Competition
In8bio Inc is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 6.66 Billion. In8bio adds roughly 23.49 Million in current valuation claiming only tiny portion of equities under Health Care industry.
In8bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in In8bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, In8bio will eventually generate negative long term returns. The profitability progress is the general direction of In8bio's change in net profit over the period of time. It can combine multiple indicators of In8bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -38 M | -36.1 M | |
| Operating Income | -30.3 M | -28.8 M | |
| Net Loss | -30 M | -28.5 M | |
| Income Before Tax | -30 M | -28.5 M | |
| Total Other Income Expense Net | 379.5 K | 398.5 K | |
| Net Loss | -13.2 M | -13.8 M | |
| Net Loss | -30 M | -28.5 M | |
| Income Tax Expense | -32.8 M | -31.2 M | |
| Change To Netincome | 2.5 M | 2.7 M | |
| Net Loss | (1.00) | (1.05) | |
| Income Quality | 0.78 | 1.03 | |
| Net Income Per E B T | 0.87 | 0.77 |
In8bio Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on In8bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of In8bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the In8bio's important profitability drivers and their relationship over time.
Use In8bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if In8bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will appreciate offsetting losses from the drop in the long position's value.In8bio Pair Trading
In8bio Inc Pair Trading Analysis
The ability to find closely correlated positions to In8bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace In8bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back In8bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling In8bio Inc to buy it.
The correlation of In8bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as In8bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if In8bio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for In8bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your In8bio position
In addition to having In8bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electronic Equipment Thematic Idea Now
Electronic Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electronic Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronic Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
To fully project In8bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of In8bio Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include In8bio's income statement, its balance sheet, and the statement of cash flows.